3rd Quarter - Report

WILLIAMS AND JENSEN, PLLC for GENENTECH INC

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

General tax issues. Implementation of the Tax Cuts and Jobs Act (P.L. 115-97). Orphan Drug Tax Credit issues.

LobbyistCovered position, as disclosed
CHRISTOPHER W HATCHER —
KARINA LYNCH —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

General education about policies impact pharmaceutical development, approval, and reimbursement including Medicare payment policies. Medicare Part D. S. 2543, Prescription Drug Pricing Reduction Act (PDPRA) of 2019 and H.R. 3, Lower Drug Costs Now Act of 2019.

LobbyistCovered position, as disclosed
CHERYL LYNN JAEGER Shared employee, Ofc of the Speaker & Ofc of VA 7; Sr Policy Adv, Majority Leader, Rep Eric Cantor; Sr Policy Adv, Republican Whip, Rep Eric Cantor; Sr Policy Adv, Majority Whip, Rep. Roy Blunt; Prof Staff House Committee on E&C; Sr LA to Rep C Cox
KARINA LYNCH —
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; White House Office

Bills named: S. 2543 (116th), H.R. 3 (116th)

Budget/Appropriations BUD

Policies impacting drug development and public health preparedness.

LobbyistCovered position, as disclosed
CHERYL LYNN JAEGER Shared employee, Ofc of the Speaker & Ofc of VA 07; Sr Policy Adv, Maj Leader, Rep. Cantor; Sr Policy Adv, Republican Whip, Rep. Cantor; Sr Policy Adv, Majority Whip, Rep. Blunt; Prof Staff House Committee on E & C; Sr LA to Rep. Cox

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office

Health Issues HCR

General education about federal policies impact pharmaceutical development, approval, and reimbursement (including Medicare, Medicaid, ACA issues). General education about FDA approval policies; Drug pricing under 340B Program; IPI drug pricing proposal. S. 2543, Prescription Drug Pricing Reduction Act (PDPRA) of 2019 and H.R. 3, Lower Drug Costs Now Act of 2019.

LobbyistCovered position, as disclosed
CHERYL LYNN JAEGER —
KARINA LYNCH —
GEORGE OLSEN —
CHRISTOPHER E. WILCOX Regional Staff Asst & Staff Asst, Sen. Moynihan ;LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Bills named: H.R. 3 (116th), S. 2543 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.